David Winter becomes president and chief operating officer of SangStat; Philippe Pouletty elected chairman.MENLO PARK, Calif.--(BUSINESS WIRE)--Feb. 27, 1995--SangStat, The Transplant Company (Nasdaq:SANG) Monday announced that David L. Winter, M.D., had been named president and chief operating officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. (COO) of the company. Winter, 61, formerly president and chief operating officer of GenPharm U.S., GenPharm International Inc., of Mountain View, assumes the presidency from Philippe Pouletty, M.D., a founder of the company. Pouletty, 36, was elected chairman of the board and will continue as chief executive officer (CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. ). Prior to joining GenPharm, Winter served for nearly fifteen years in a range of senior medical and scientific positions with various U.S. units of Sandoz Ltd. Most recently, he was vice president, scientific and external affairs, of Sandoz Pharmaceuticals Corporation, East Hanover, New Jersey East Hanover Township is a township in Morris County, New Jersey, United States. As of the United States 2000 Census, the township population was 11,393. Incorporated in 1928, it is a largely middle to upper-income suburban community situated roughly 25 miles west of New York City. , a position he attained in 1989, after serving as vice president, clinical research and development of Sandoz Research Institute. "SangStat is rapidly emerging as both a provider of products and research tools to the transplantation community and as a leader in the scientific and clinical pursuit of new approaches to graft acceptance, long-term graft viability and greater patient independence," said Philippe Pouletty, chief executive officer. "David brings extensive and relevant research, development and clinical experience and also business management expertise specifically related to the worldwide transplantation market." "Organ transplantation is on the threshold of rapid change and expansion and SangStat is well positioned to take advantage of this opportunity," Winter said. "We are addressing the challenges posed by the immune system in transplanting human and other organs and tissues and are broadening medical opportunities for transplants and significantly altering post-transplant care. This is a very exciting place to be." A physician/neurophysiologist, Winter began his career in the division of neuropsychiatry neuropsychiatry /neu·ro·psy·chi·a·try/ (noor?o-si-ki´ah-tre) the combined specialties of neurology and psychiatry. neu·ro·psy·chi·a·try n. , Walter Reed Army Institute of Research This article is about the U.S. Army medical research institute (not the hospital). Otherwise, see Walter Reed (disambiguation). The Walter Reed Army Institute of Research (WRAIR) is the largest biomedical research facility administered by the U.S. . Subsequently he was NASA NASA: see National Aeronautics and Space Administration. NASA in full National Aeronautics and Space Administration Independent U.S. director of life sciences where he directed all the medical and biomedical engineering activity for the U.S. space program. He has an M.D. from the Washington University School of Medicine Washington University School of Medicine, located in St. Louis, Missouri, is one of the most competitive and highly regarded medical schools and biomedical research institutes in the United States. in St. Louis and an A.B. from Columbia College, New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Pouletty founded SangStat in 1988 with Dr. David Rammler and served as president and CEO. Previously he had been director of research at Clonatec, a French diagnostics company he co-founded. As chairman he succeeds Gordon Russell, a general partner of Sequoia Capital, who has served in this position since 1992. Russell, 61, will remain a director of the company. SangStat is a biopharmaceutical company dedicated to disease management in the field of organ transplantation. Of SangStat's eleven products and product candidates, one is a licensed-in, commercially-proven drug, three are currently available for clinical and research use and several others are at an advanced stage of development. SangStat's drug candidates include THYMOGLOBULIN to treat graft rejection, CLYCLOSPORINE for chronic immunosuppresive therapy and ALLOTRAP to promote graft acceptance following transplantation. THYMOGLOBULINE (exclusive marketing and development rights from Pasteur Merieux Serums et Vaccins "PMsv" for the U.S. and Canada) has been submitted for new drug approval in Canada, and is in a Phase III clinical trial Noun 1. phase III clinical trial - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the in the U.S. The second drug candidate, CYCLOSPORINE, is in development; and ALLOTRAP is in early Phase II clinical trials in France. Monitoring products include PRA-STAT (marketed in the U.S. and Europe) and candidates CROSS-STAT and TYP-STAT. These three products, intended to improve donor/recipient compatibility, are licensed exclusively worldwide to Baxter Healthcare Corporation. Other product candidates, QUANTSTAT, TRANSTAT and sHLA-STAT Class I are intended to guide post-transplant therapy; CELSIOR (exclusively licensed from PMsv) is an organ preservation solution; and drug candidate XE-9 is in early development for xenotransplantation xen·o·trans·plan·ta·tion n. The surgical transfer of cells, tissues, or especially whole organs from one species to another. xenotransplantation . SangStat is located in Menlo Park, California Menlo Park is a city in San Mateo County, California in the United States of America. It is located at latitude 37°29' North, longitude 122°9' East. Menlo Park had 30,785 inhabitants as of the 2000 U.S. Census. , and operates wholly-owned subsidiaries XenoStat Inc. in Menlo Park, California, SangStat Atlantique S.A. in Nantes, France and SangStat Canada Ltd. in Mississauga, Ontario, Canada. CONTACT: SangStat Philippe Pouletty, 415/328-0300 Russell-Welsh Inc. Katharine A. Russell, 415/312-0700 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion